Earum Pharmaceuticals Limited
ListedSMEHealthcare & Pharmaceuticals · BSE
Incorporated in 2012, Ahmedabad-based Earum Pharmaceuticals Limited is engaged in the trading, marketing, and distribution of pharmaceutical formulation products, with a portfolio of around 125 formulations including multivitamins, gynaecology drugs, steroids, antibiotics, cerebral activators, and gastrointestinal medicines. The company is also involved in trading active pharmaceutical ingredients such as Amoxicillin Trihydrate IP, Levofloxacin Hemihydrate IP, and Albendazole IP, and operates through two main business models—marketing its own branded formulations and trading generic formulations of other brands, with about 24 products manufactured by third parties and sold under its own brand. Earum Pharmaceuticals operates a well-equipped warehouse in Ahmedabad, Gujarat, and has a presence in both domestic and international markets including South East Asia, Latin America, and Africa, while focusing on expanding its global footprint, improving market capabilities, and maintaining high-quality product standards.
Price Band
₹36
Issue Size
₹7.00 Cr
Lot Size
3000 shares
GMP
—
Est. Listing
₹36
at current GMP
Subscribed
—
Open
21 Jun 2019
Close
26 Jun 2019
Allotment
1 Jul 2019
Refund
2 Jul 2019
Demat Credit
3 Jul 2019
Listing
4 Jul 2019
Last updated 12 days ago
Overall Subscription
0.00x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
0.00x
High Net-Worth
Retail (RII)
0.00x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| Qualified Institutional (QIB) | 972,222 | — | 0.00x |
| Non-Institutional (NII / HNI) | 291,667 | — | 0.00x |
| Retail Individual (RII) | 680,556 | — | 0.00x |
| Total | 1,944,445 | 0 | 0.00x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 227 | 227 | 1.00x |
| HNIs (10L +) | 1 | 1 | 1.00x |
| HNIs (2-10L) | 7 | 7 | 1.00x |
| Total Applications | 235 | 235 | 1.00x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Earum Pharmaceuticals Limited Public Issue & Market Profile
Earum Pharmaceuticals Limited is bringing an initial public offering (IPO) in the Healthcare & Pharmaceuticals sector with an aggregate issue size of ₹7 Crores. The shares are offered at a price band of ₹36 to ₹36 per equity share on BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Bidding & Quota Instructions:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 3000 shares (approx. ₹1,08,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment Reconciliation Schedule:
Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2019-07-03, while un-allotted funds or UPI block mandates will be released on 2019-07-02.
Frequently Asked Questions
What is Earum Pharmaceuticals Limited IPO GMP today?
Currently, Earum Pharmaceuticals Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹36 to ₹36 per equity share.
What is the expected profit per lot for Earum Pharmaceuticals Limited IPO?
The retail lot size is 3000 shares requiring a minimum application amount of ₹1,08,000. Expected listing price is ₹36 per equity share.
What is the issue size and price band for Earum Pharmaceuticals Limited IPO?
The Earum Pharmaceuticals Limited IPO aggregate issue size is ₹7 Crores with an equity price band set at ₹36 to ₹36 per equity share. The retail lot size is 3000 shares requiring a minimum capital outlay of approx. ₹1,08,000.
How can I check Earum Pharmaceuticals Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 0.00x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.
Where and when will Earum Pharmaceuticals Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2019-07-01. Investors can verify status using PAN card or application number.
When is the listing date for Earum Pharmaceuticals Limited IPO?
Earum Pharmaceuticals Limited shares are scheduled to list on BSE on 2019-07-04.